The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
95 percent of experimental agents that we bring to the bedside today 95 percent in cancer fail completely the five percent that succeed should have failed because they are only prolonging survival for 20 to 30 percent of patients by a few months
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
95 percent of experimental agents that we bring to the bedside today 95 percent in cancer fail completely